February 20, 2018 / 1:21 PM / 8 months ago

BRIEF-Fate Therapeutics Announces First Subject Treated With Fate-NK100 In Dimension Study For Advanced Solid Tumors

Feb 20 (Reuters) - Fate Therapeutics Inc:

* FATE THERAPEUTICS ANNOUNCES FIRST SUBJECT TREATED WITH FATE-NK100 IN DIMENSION STUDY FOR ADVANCED SOLID TUMORS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below